Key result
African Americans show lower urinary F2-isoprostane levels than whites, with no association to BMI.
Why the study?
Although positive cross-sectional associations between systemic F2-isoprostane levels and BMI have been consistently demonstrated across populations, racial differences in urinary F2-isoprostane levels and their relationship with BMI required characterization.
Does African American race/ethnicity modify urinary F2-isoprostane levels and their cross-sectional association with body mass index compared to non-Hispanic and Hispanic whites in adults without diabetes?
Cross-Sectional (n=854)
Yes
Does African American race/ethnicity modify urinary F2-isoprostane levels and their cross-sectional association with body mass index compared to non-Hispanic and Hispanic whites in adults without diabetes?
Answers are grounded in this paper and cite their sources.
Unlike white individuals who exhibit a positive correlation between BMI and urinary F2-isoprostanes, African Americans have lower overall F2-isoprostane levels and show no increase with higher BMI, suggesting racial differences in obesity-related oxidative fat metabolism.
Levels of four urinary F(2)-isoprostanes (F(2)-IsoPs) were examined in a large sample of the Insulin Resistance Atherosclerosis Study (IRAS) multiethnic cohort: 237 African Americans (AAs), 342 non-Hispanic whites (NHWs), and 275 Hispanic whites (HWs). F(2)-IsoP isomers - iPF2a-III, 2,3-dinor-iPF2a-III, iPF2a-VI, and 8,12-iso-iPF2a-VI - were measured in 854 urine samples using liquid chromatography with tandem mass spectrometry detection. In AAs, levels of all four F(2)-IsoPs were lower compared with NHWs and HWs (P values <0.05). When stratified by BMI, this gap was not observed among participants with normal BMI but appeared among overweight participants and increased among obese participants. Examining the slopes of the associations between BMI and F(2)-IsoPs showed no association between these variables among AAs (P values >0.2), and positive associations among whites (P values <0.05). Taking into account that positive cross-sectional associations between systemic F(2)-IsoP levels and BMI have been consistently demonstrated in many study populations, the lack of such an association among AAs reveals a new facet of racial/ethnic differences in obesity-related risk profiles.
No takes yet. Share an insight, caveat, or question.
Il’yasova et al. (2012) conducted a cross-sectional in Normal or impaired glucose tolerance (n=854). African American race/ethnicity and body mass index (BMI) vs. Non-Hispanic Whites and Hispanic Whites (Caucasians) was evaluated on Urinary F2-isoprostane isomers (iPF2α-III, 2,3-dinor-iPF2α-III, iPF2α-VI, and 8,12-iso-iPF2α-VI) levels and their association with BMI (p=<0.05). African Americans had lower levels of all four urinary F2-isoprostanes than non-Hispanic and Hispanic whites and showed no association between F2-IsoPs and BMI.
Synapse has enriched 10 related papers. Consider them for comparative context: